Literature DB >> 15301044

The use of L-T4 as liquid solution improves the practicability and individualized dosage in newborns and infants with congenital hypothyroidism.

J H von Heppe1, H Krude, D L'Allemand, D Schnabel, A Grüters.   

Abstract

UNLABELLED: Dosage recommendations for the initial therapy of congenital hypothyroidism (CH) in newborns vary between 8 microg/kg/d and 10-15 microg/kg/d. AIM: To evaluate the practicability of LT4 in liquid form and to define the initial dosage for optimal treatment.
METHODS: Liquid LT4 solution was administered to 28 consecutive newborns with primary CH. We measured TSH, T3, T4, free T3 and free T4 before therapy and during follow-up up to 2 years. After 2 years a standardized developmental test (Griffith) was performed.
RESULTS: The median dosage at start of therapy was 12.3 microg LT4/kg/d and decreased to about 5 microg LT4/kg/d after 9 months. The median time of normalization of TSH (< or =6 mU/l) was 2 weeks. In 21 patients, who received a median starting dosage of 12.7 microg LT4/kg (range 9.8-17.1 microg/kg), TSH levels normalized within a median of 1 week. Seven patients receiving only 10.1 microg LT4/kg normalized their TSH only after a median of 2 months.
CONCLUSIONS: Newborns with CH should normalize their TSH within 1-2 weeks. The initial dose necessary to normalize TSH is not lower when a liquid solution is used. The higher dose used in tablets is not due to inefficient absorption, but rather reflects the increased demand for thyroid hormone in the first weeks of life.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15301044     DOI: 10.1515/jpem.2004.17.7.967

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  4 in total

Review 1.  Detection and treatment of congenital hypothyroidism.

Authors:  Annette Grüters; Heiko Krude
Journal:  Nat Rev Endocrinol       Date:  2011-10-18       Impact factor: 43.330

Review 2.  Liquid and softgel levothyroxine use in clinical practice: state of the art.

Authors:  Camilla Virili; Pierpaolo Trimboli; Francesco Romanelli; Marco Centanni
Journal:  Endocrine       Date:  2016-07-29       Impact factor: 3.633

Review 3.  The Italian screening program for primary congenital hypothyroidism: actions to improve screening, diagnosis, follow-up, and surveillance.

Authors:  A Cassio; C Corbetta; I Antonozzi; F Calaciura; U Caruso; G Cesaretti; R Gastaldi; E Medda; F Mosca; E Pasquini; M C Salerno; V Stoppioni; M Tonacchera; G Weber; A Olivieri
Journal:  J Endocrinol Invest       Date:  2013-02-12       Impact factor: 4.256

4.  European Society for Paediatric Endocrinology consensus guidelines on screening, diagnosis, and management of congenital hypothyroidism.

Authors:  Juliane Léger; Antonella Olivieri; Malcolm Donaldson; Toni Torresani; Heiko Krude; Guy van Vliet; Michel Polak; Gary Butler
Journal:  J Clin Endocrinol Metab       Date:  2014-01-21       Impact factor: 5.958

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.